BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27981439)

  • 41. Development of the Nocturia Sleep Quality Scale: a patient-reported outcome measure of sleep impact related to nocturia.
    Romano CD; Lewis S; Barrett A; Andersson FL; Williams V; Ancoli-Israel S; Roth T
    Sleep Med; 2019 Jul; 59():101-106. PubMed ID: 31072693
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire.
    Swigris JJ; Andrae DA; Churney T; Johnson N; Scholand MB; White ES; Matsui A; Raimundo K; Evans CJ
    Am J Respir Crit Care Med; 2020 Dec; 202(12):1689-1697. PubMed ID: 32634038
    [No Abstract]   [Full Text] [Related]  

  • 43. Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument.
    McCarrier KP; Atkinson TM; DeBusk KP; Liepa AM; Scanlon M; Coons SJ;
    Clin Ther; 2016 Apr; 38(4):794-810. PubMed ID: 27041408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Caregiver Burden Questionnaire for Heart Failure (CBQ-HF): face and content validity.
    Humphrey L; Kulich K; Deschaseaux C; Blackburn S; Maguire L; Strömberg A
    Health Qual Life Outcomes; 2013 May; 11():84. PubMed ID: 23706131
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis.
    Dulai PS; Jairath V; Khanna R; Ma C; McCarrier KP; Martin ML; Parker CE; Morris J; Feagan BG; Sandborn WJ
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1047-1066. PubMed ID: 32319120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of the Hypogonadism Impact of Symptoms Questionnaire Short Form: Qualitative Research.
    Gelhorn HL; Bodhani AR; Wahala LS; Sexton C; Landrian A; Miller MG; Derogatis L; Dobs A; Revicki DA
    J Sex Med; 2016 Nov; 13(11):1729-1736. PubMed ID: 27717790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of the Osteoporosis Assessment Questionnaire--physical Function (OPAQ-PF): an osteoporosis-targeted, patient-reported outcomes (PRO) measure of physical function.
    Naegeli AN; Nixon A; Burge R; Gold DT; Silverman S
    Osteoporos Int; 2014 Feb; 25(2):579-88. PubMed ID: 23929004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Qualitative concept elicitation and cognitive debriefing interviews of symptoms, impacts and selected customized PROMIS
    Findley A; Middlehurst JM; Howse CA; Clifford MJ; Neill W; Tatlock S; Chen WH; Bracher MG; Patel DS
    J Patient Rep Outcomes; 2023 Apr; 7(1):39. PubMed ID: 37079188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of a patient-reported outcome (PRO) measure to assess patient perceptions of simplicity and complexity of treatment for type 2 diabetes.
    Stewart KD; Matza LS; Patel H; Boye KS
    J Patient Rep Outcomes; 2023 Sep; 7(1):89. PubMed ID: 37672123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of the Impact of Nighttime Urination (INTU) questionnaire to assess the impact of nocturia on health and functioning.
    Abrams S; Martin S; Gillard KK; Cheng L; Fein S
    Neurourol Urodyn; 2018 Jun; 37(5):1686-1692. PubMed ID: 29566269
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a next day functioning measure to assess the impact of sleep disturbance due to restless legs syndrome: the restless legs syndrome-next day impact questionnaire.
    Lasch KE; Abraham L; Patrick J; Piault EC; Tully SE; Treglia M
    Sleep Med; 2011 Sep; 12(8):754-61. PubMed ID: 21824819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An insight into statin use and its association with muscular side effects in clinical practice.
    Farcas A; Bucsa C; Leucuta D; Mogosan C; Bojita M; Dumitrascu D
    Rom J Intern Med; 2015; 53(2):153-60. PubMed ID: 26402985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Statin associated myopathy in clinical practice. Results of DAMA study].
    Millán J; Pedro-Botet J; Climent E; Millán J; Rius J
    Clin Investig Arterioscler; 2017; 29(1):7-12. PubMed ID: 27717598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Content validation of a daily patient-reported outcome measure for assessing symptoms in patients with Small Intestinal Bacterial Overgrowth.
    Durgam N; Dashputre AA; Moshkovich O; Rezaie A; Martinez N; Enayati P; Stansbury J; Joseph G
    Qual Life Res; 2023 Sep; 32(9):2573-2585. PubMed ID: 37212941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Qualitative evaluation of the St George's Respiratory Questionnaire in patients with severe asthma.
    Nelsen LM; Kimel M; Murray LT; Ortega H; Cockle SM; Yancey SW; Brusselle G; Albers FC; Jones PW
    Respir Med; 2017 May; 126():32-38. PubMed ID: 28427547
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of the Statin-Associated Muscle Symptoms-Clinical Index to a Randomized Trial on Statin Myopathy.
    Taylor BA; Sanchez RJ; Jacobson TA; Chibedi-De-Roche D; Manvelian G; Baccara-Dinet MT; Khan I; Rosenson RS
    J Am Coll Cardiol; 2017 Sep; 70(13):1680-1681. PubMed ID: 28935043
    [No Abstract]   [Full Text] [Related]  

  • 57. Novel Questionnaires for Assessing Signs and Symptoms of Eosinophilic Esophagitis in Children.
    Kamat S; Yaworsky A; Guillemin I; Krohe M; Litcher-Kelly L; McLafferty M; Lamoureux RE; Lowe C; Chehade M; Spergel JM; Weinfurt K; Turner-Bowker DM
    J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1856-1863.e3. PubMed ID: 35398552
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and content validity of the Barth Syndrome Symptom Assessment (BTHS-SA) for adolescents and adults.
    Gwaltney C; Stokes J; Aiudi A; Mazar I; Ollis S; Love E; Shields A
    Orphanet J Rare Dis; 2021 Jun; 16(1):264. PubMed ID: 34108006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Qualitative Interviews to Better Understand the Patient Experience and Evaluate Patient-Reported Outcomes (PRO) in RLBP1 Retinitis Pigmentosa (RLBP1 RP).
    Green J; Tolley C; Bentley S; Arbuckle R; Burstedt M; Whelan J; Holopigian K; Stasi K; Sloesen B; Spera C; Deslandes JY; Mullins A
    Adv Ther; 2020 Jun; 37(6):2884-2901. PubMed ID: 32372289
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of a Patient-Reported Outcome Measure for Chronic Hypoparathyroidism.
    Martin S; Chen K; Harris N; Vera-Llonch M; Krasner A
    Adv Ther; 2019 Aug; 36(8):1999-2009. PubMed ID: 31183782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.